One of the leading compounds—adenosine 5’-monophosphate (A5MP) was able to halt the proliferation of BRCA1-deficient HCC1937 breast cancer cells and did not influence cells with restored BRCA1 expression [65]. This evidence concerns the gene BRCA1 and breast cancer.